scholarly journals Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control

2015 ◽  
Vol 19 (1) ◽  
pp. 46-52 ◽  
Author(s):  
F Ting ◽  
M Tran ◽  
M Böhm ◽  
A Siriwardana ◽  
P J Van Leeuwen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Functional Outcomes ◽  
Irreversible Electroporation ◽  
Short Term

scholarly journals Irreversible Electroporation for Prostate Cancer

Life ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 490
Author(s):  
Sean Ong ◽  
Matthew Leonardo ◽  
Thilakavathi Chengodu ◽  
Dominic Bagguley ◽  
Nathan Lawrentschuk
Keyword(s):  
Prostate Cancer ◽  
Functional Outcomes ◽  
Irreversible Electroporation ◽  
Focal Therapy ◽  
Safe Procedure ◽  
Short Term ◽  
Electrical Currents ◽  
Treatment Side Effects ◽  
Oncological Outcomes ◽  
Treat All

Although it can be lethal in its advanced stage, prostate cancer can be effectively treated when it is localised. Traditionally, radical prostatectomy (RP) or radiotherapy (RT) were used to treat all men with localised prostate cancer; however, this has significant risks of post-treatment side effects. Focal therapy has emerged as a potential form of treatment that can achieve similar oncological outcomes to radical treatment while preserving functional outcomes and decreasing rates of adverse effects. Irreversible electroporation (IRE) is one such form of focal therapy which utilises pulsatile electrical currents to ablate tissue. This modality of treatment is still in an early research phase, with studies showing that IRE is a safe procedure that can offer good short-term oncological outcomes whilst carrying a lower risk of poor functional outcomes. We believe that based on these results, future well-designed clinical trials are warranted to truly assess its efficacy in treating men with localised prostate cancer.

scholarly journals Focal Ablation Therapies in Prostate Cancer

2021 ◽  
Author(s):  
Öztuğ Adsan
Keyword(s):  
Prostate Cancer ◽  
Recent Literature ◽  
Irreversible Electroporation ◽  
Published Data ◽  
Side Effect Profile ◽  
Short Term ◽  
Focal Ablation ◽  
Oncological Results ◽  
Acceptable Side

Focal ablation therapies in prostate cancer have been actively evaluated in the light of recent literature. According to published data,focal ablation therapies appear to be well tolerated and have an acceptable side effect profile. Moreover, while clinical outcomes were not homogenous, short-term oncological results of some focal ablation therapies such as laser and irreversible electroporation (IRE) have been found as good as curative ones. While waiting long-term oncological results, focal ablation therapies in prostate cancer are beinmg used increasingly.

Robot-Assisted Radical Prostatectomy for the Treatment of Radiation-Resistant Prostate Cancer: Surgical, Oncological and Short-Term Functional Outcomes

2014 ◽  
Vol 92 (1) ◽  
pp. 20-26 ◽  
Author(s):  
Vahudin Zugor ◽  
Apostolos P. Labanaris ◽  
Daniel Porres ◽  
Axel Heidenreich ◽  
Jorn H. Witt
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Functional Outcomes ◽  
Robot Assisted ◽  
Short Term ◽  
Radiation Resistant

Docetaxel, estramustine, and short-term androgen withdrawal for patients with biochemical failure after definitive local therapy for prostate cancer

2001 ◽  
Vol 28 (4M) ◽  
pp. 32-39 ◽  
Author(s):  
Mary-Ellen Taplin ◽  
Glenn J. Bubley ◽  
Barur Rajeshkumar ◽  
Todd Shuster ◽  
Yoo-Joung Ko ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Local Therapy ◽  
Biochemical Failure ◽  
Short Term ◽  
Androgen Withdrawal
Sign in / Sign up

Export Citation Format

Share Document